SCHEMBL22559533

SCHEMBL22559533

Cc1ccc(C(=O)Nc2ccc(CO)c(Cl)c2)cc1C#Cc1cnc2cccnn12

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 15/20 0.78
CYP3A4 P08684 6/20 0.78
KCNH2 Q12809 6/20 0.78
LCK P06239 3/20 0.71
SRC P12931 3/20 0.71
PDGFRA P16234 3/20 0.71
EPHB2 P29323 3/20 0.71
EPHB3 P54753 3/20 0.71
EPHB4 P54760 3/20 0.71
NEK6 Q9HC98 2/20 0.71
DDR2 Q16832 2/20 0.71
MAP4K3 Q8IVH8 1/20 0.71
ROR1 Q01973 3/20 0.68
CSF1R P07333 2/20 0.67
ABL2 P42684 2/20 0.64
GAK O14976 1/20 0.64
MLNR O43193 1/20 0.64
RIPK2 O43353 1/20 0.64
JAK2 O60674 1/20 0.64
NR1I2 O75469 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22559443 0.93 ABL1 (0.78) ABL1CYP3A4KCNH2LCKSRC
SCHEMBL18298082 0.89 ABL1 (0.80) ABL1CYP3A4KCNH2LCKSRC
SCHEMBL31697365 0.89 ABL1 (0.80) ABL1CYP3A4KCNH2LCKSRC
SCHEMBL22559505 0.88 ABL1 (1.00) ABL1CYP3A4KCNH2LCKSRC
SCHEMBL12989619 0.88 ABL1 (1.00) ABL1CYP3A4KCNH2LCKSRC
SCHEMBL589689 0.88 ABL1 (1.00) ABL1CYP3A4KCNH2LCKSRC
SCHEMBL16644466 0.87 CSF1R (0.75) ABL1CYP3A4KCNH2LCKSRC
SCHEMBL22559451 0.87 CSF1R (0.70) ABL1CYP3A4KCNH2LCKSRC
SCHEMBL22559454 0.85 CYP3A4 (1.00) ABL1CYP3A4KCNH2LCKSRC
SCHEMBL22559453 0.85 CYP3A4 (0.76) ABL1CYP3A4KCNH2LCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020214999-A1 ABELSON NON-TYROSINE KINASE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES EMORY UNIVERSITY (US) 2020-10-22 WO disclosed